Ann: Australian institution to invest $2.7 million in OSL, page-16

You may recall the history of Sirtex, including the involvement of Peter Hall?

For those unfamiliar, a simple Google search would provide ample details.

Ricky Sharma's appointment to OSL's board initially generated interest due to his scientific credentials and experience at Varian. However, his subsequent departure raised questions about the company's trajectory. If OSL's technology held substantial near-term promise, one might expect varian would have acquired the company while Ricky was on board.

whytee and cafa knows more about sirtex and what happened; than most stock pumper would tell you on this forum. Comparing OSL with sirtex is nothing but immaturity of the poster at this stage. The broader landscape of pancreatic cancer treatments is evolving rapidly, with numerous companies developing alternative therapies. This competitive environment adds to the challenges faced by OSL.


https://portal.omnibridgeway.com/cases/detail/sirtex-medical-ltd

https://asic.gov.au/about-asic/news-centre/find-a-media-release/2020-releases/20-127mr-former-ceo-and-director-of-sirtex-medical-limited-sentenced-for-insider-trading/

https://www.spglobal.com/marketintelligence/en/news-insights/blog/japan-ma-by-the-numbers-q4-2023

disallowed/business/markets/sirtex-chairman-richard-hill-says-it-was-very-difficult-to-let-exceo-gilman-wong-go-20171024-gz6ufu.html

https://takeovers.gov.au/reasons-decisions/2003-atp-22

Abstract from the article below:

disallowed/business/fund-manager-peter-hall-loses-27m-as-he-seals-exit-with-sale-to-soul-pattinson-20161230-gtjx06.html



use SMH instead of disallowed.